In cells that allow replication of vesicular stomatitis virus (VSV) there are two phases of translation inhibition: an early block of host translation, and a later inhibition of viral translation. We investigated the phosphorylation of the alpha subunit of the eIF2 complex during these two phases of viral infection. In VSV-infected cells, the accumulation of phosphorylated (inactivated) eIF2 did not begin until well after host protein synthesis was inhibited, suggesting that it only plays a role in blocking viral 
Summary
In cells that allow replication of vesicular stomatitis virus (VSV) there are two phases of translation inhibition: an early block of host translation, and a later inhibition of viral translation. We investigated the phosphorylation of the alpha subunit of the eIF2 complex during these two phases of viral infection. In VSV-infected cells, the accumulation of phosphorylated (inactivated) eIF2 did not begin until well after host protein synthesis was inhibited, suggesting that it only plays a role in blocking viral translation at later times postinfection. Consistent with this, cells expressing an unphosphorylatable eIF2 showed prolonged viral protein synthesis without an effect on host protein synthesis inhibition. Induction of eIF2 phosphorylation at early times of viral infection by treatment with thapsigargin showed that virus and host translation are similarly inhibited, demonstrating that viral and host messages are similarly sensitive to eIF2a phosphorylation. A recombinant virus that expresses a mutant matrix protein and is defective in the inhibition of host and virus protein synthesis showed an altered phosphorylation of eIF2 demonstrating an involvement of viral protein function in inducing this antiviral response. This analysis of eIF2 phosphorylation, coupled with earlier findings that the eIF4F complex is modified earlier during VSV infection support a temporal/kinetic model of translation control, where at early times postinfection changes in the eIF4F complex result in the inhibition of host protein synthesis, and at later times inactivation of the eIF2 complex blocks VSV protein synthesis.
Introduction
Many viruses can selectively inhibit host translation and still use the host translation machinery to synthesize their own proteins (for reviews see (1,2), and (3)).
This provides two advantages for viral replication. It facilitates the rapid production of viral proteins, and it can also inhibit the production of host antiviral proteins (4) . Both factors are important in the race of the virus against the cellular antiviral response. On the other hand, a critical part of the cellular antiviral response is the global inhibition of translation that blocks viral protein synthesis, effectively dampening virus production (5).
The inhibition of both host and viral translation are apparent during infection with the prototype rhabdovirus vesicular stomatitis virus (VSV). During VSV infection, there is a rapid inhibition of host mRNA translation at early times postinfection. This block of host translation is followed by a later inhibition of viral mRNA translation (6) . The experiments presented here address the question of whether these two events reflect differing sensitivities of viral and host mRNAs to a single translation inhibition response or whether there are separate mechanisms controlling each inhibitory event.
A substantial body of evidence implicates the phosphorylation of the initiation factor eIF2 as a major player in inhibiting viral translation (5) . EIF2 is a subunit of eIF2, the multi-protein complex that is responsible for recruiting the initiator tRNA to the 40S subunit of the ribosome in a GTP-dependant manner. Phosphorylation of eIF2 inhibits the exchange of GDP for GTP and inhibits translation initiation by blocking the recruitment of the initiator methionine tRNA. The phosphorylation of eIF2 can be carried out by several different kinases (7), but during viral infection, it is the dsRNA-activated kinase PKR that is believed to be responsible for the phosphorylation of eIF2 (5) .
Early studies showed that eIF2 was inactivated in VSV-infected cells (8, 9) , and in vitro experiments showed that adding eIF2 to lysates from VSV-infected cells could restore translational activity (10) . More recent studies using cells derived from PKR knockout mice suggested that the inactivation of eIF2 was due to eIF2 phosphorylation and was primarily a function of PKR (11, 12) , though a recent publication has demonstrated that there is an additional contribution from the endoplasmic reticulum kinase PERK (13) The phosphorylation of eIF2 and inhibition of eIF2 function during VSV infection suggests two different models for the biphasic inhibition of host and then viral protein synthesis. The first is that eIF2 is the dominant complex that controls host and viral translation in VSV-infected cells, but that VSV messages are more resistant to eIF2 inhibition than are host messages. This would be a situation similar to that seen for cricket paralysis virus mRNAs and some cellular mRNAs (14, 15) . The second model is that there are distinct mechanisms that regulate the early inhibition of host and the late inhibition of viral protein synthesis, and that eIF2 is responsible for only one of these events.
Support for the latter model has come from recent studies showing the alteration of the eIF4F initiation factor complex in VSV-infected cells (16) . The eIF4F complex is a multi-protein complex that contains the cap-binding protein eIF4E, the scaffolding protein eIF4G, the helicase eIF4A, the protein kinase MNK1 as well as additional proteins (17) . This complex is responsible for binding to the m7-GTP cap of mRNAs and bringing them to the 40S ribosome complex. We showed that following VSV infection there is a rapid alteration of the eIF4F complex, indicated by the dephosphorylation of the eIF4E subunit (16) , which was correlated with the inhibition of host protein synthesis.
The dephosphorylation of eIF4E was associated with the activation of the eIF4E binding protein eIF4E-BP1/PHAS1, a protein that is known to dissociate eIF4E from the eIF4F complex, although additional mechanisms also contribute to eIF4E dephosphorylation (16) . These studies did not, however, determine whether there were concurrent alterations in eIF2 phosphorylation that might also contribute to the inhibition of host protein synthesis.
In this report we analyzed the role of eIF2 phosphorylation in the inhibition of host versus viral translation during VSV infection. The results showed that eIF2a phosphorylation occurs after host protein synthesis is in inhibited, suggesting that eIF2a phosphorylation does not play a role in inhibiting host protein synthesis. Consistent with this, a dominant active form of eIF2 that cannot be phosphorylated had no effect on host translation inhibition. EIF2a phosphorylation did appear to be sufficient for the inhibition of viral protein synthesis, as pharmacological inducers of eIF2a phosphorylation blocked viral protein synthesis even at early times postinfection, and a viral mutant that expresses viral proteins for a longer period of time than the wild-type virus did not induce the phosphorylation of eIF2a to the same extent as the wild-type virus showing that the viral M protein can play a role in the induction of eIF2a phosphorylation.
Materials and Methods.
Chemicals, unless otherwise stated, were purchased from Fisher Scientific. Thapsigargin was purchased from Calbiochem. Antibodies against eIF2 and phospho-eIF2 , were purchased from Cell Signaling Technologies. Okadaic acid and microcystin were purchased from Alexis Pharmaceuticals. Wild-type mouse embryonic fibroblasts (wt MEFs) expressing wt eIF2 and MEFs expressing a form of eIF2 where the phosphorylated serine 51 residue was mutated to alanine (S51A MEFs) were kindly provided by Donalyn Scheuner and Randall J. Kaufmann (18) .
Virus Infections:
BHK cells were cultured in Dulbecco's Modified Eagle Medium (DMEM, Gibco-BRL) containing 10% fetal bovine serum (FBS) and 2mM glutamine. Cells were grown to 80-90% confluency and were infected with wild-type (wtO) VSV (Indiana serotype, Orsay strain), recombinant wild-type (rwt), or recombinant M51R M protein mutant (rM51R-M) virus (19) in DMEM with 10% FBS at a multiplicity of 10 pfu/cell in a small volume (500ul per well for a 6 well dish). At 1 hour postinfection, the culture volume was doubled by addition of DMEM + 10% FBS.
Immmunoblotting.
Infected or mock-infected cells were lysed in 6-well dishes using 400ul EBC buffer containing 1mM phenylmethylethylfluoride (PMSF), 1mM benzamidine, 100nM okadaic acid and 100nM microcystin (16) . Lysates were spun at 10,000XG for 8 min in a refrigerated centrifuge, and 360ul of the supernatant was added to 40ul of 10X sample buffer for SDS-PAGE. Equal volumes of lysate were electrophoresed on 12% SDS-PAGE gels. Following electrophoresis, gels were electroblotted onto nitrocellulose and blocked in Tris -buffered saline (TBS, pH 7.5) + 5% dry milk. Antibodies were diluted as recommended by the manufacturers. Band intensities were quantitated by first scanning the film and then analyzing the images with Quantity One software (Biorad).
Thapsigargin treatment
BHK cells were treated with thapsigargin for 1 hour prior to 35 S labeling or lysis.
For 35 S labeling, thapsigargin was included in the initial methionine depletion step.
Thapsigargin was made as a 1mM stock in DMSO.
Metabolic labeling and rate of protein synthesis determination:
BHK cells were mock-infected or infected with VSV, and then labeled with 35 Smethionine for 10 min at varying times postinfection, as described (16) . For all experiments, three separate experiments were analyzed in this manner to determine an average.
Results

EIF2 phosphorylation occurs after host protein synthesis is inhibited in VSV-
infected cells. To determine the change in the phosphorylation of eIF2 during the inhibition of host and viral protein synthesis, we assessed eIF2a phosphorylation over a timecourse similar to that shown in figure 1A. Lysates were analyzed by western blotting, using antibodies specific for the phosphorylated and total forms of eIF2a. As a control, cells
were treated for 1 hour with 1uM thapsigargin, a pharmacological agent that induces eIF2 phosphorylation by the PERK protein kinase through destabilization of Ca ++ stores in the endoplasmic reticulum (20) . The results are shown in Figure 1D . A low level of phosphorylated eIF2 was detectable in mock-treated cells, and as expected, thapsigargin caused the rapid phosphorylation of eIF2 ( figure 1D , top left). VSV infection did cause an increase in eIF2 phosphorylation, as reported previously (11, 12) . However, this occurred long after the inhibition of host protein synthesis seen in Figure 1A . At early times postinfection, eIF2 phosphorylation was at the level of mock-infected cells.
Phosphorylation of eIF2 did not begin to noticeably increase until well after host protein synthesis was inhibited, becoming clearly elevated at 10 and 12 hours postinfection.
The extent of eIF2 phosphorylation was quantitated as a ratio of signal from the phospho-specific antibody to the signal from the total eIF2 antibody and normalized to the amount of eIF2 phosphorylation that is caused by thapsigargin treatment ( Figure   1E ). In this analysis, the phosphorylation of eIF2 in response to VSV infection did not increase significantly above mock-infected controls until 8 hours postinfection, but the level of phosphorylation by 12 hours postinfection was approximately equal to that that of thapsigargin-treated cells. This lack of significant phosphorylation until later times postinfection suggests that the inactivation of eIF2 through eIF2 phosphorylation is not involved in VSV's inhibition of host protein synthesis. However, the increase in eIF2 phosphorylation did correlate with the decrease in VSV protein synthesis, consistent with the idea that it is involved in blocking viral protein synthesis.
Host and viral protein synthesis are similarly sensitive to eIF2 phosphorylation
It has been proposed that translation of VSV messages during infection is more resistant than host messages to the phosphorylation of eIF2 (9) . A resistance of viral protein synthesis to eIF2 inactivation could account for the results seen in Figure 1A .
For example, host protein synthesis would be inhibited at early times postinfection by a level of eIF2 phosphorylation too low to be detected by the phosphospecific antibody, while at later times postinfection higher levels of eIF2 phosphorylation would block viral protein synthesis. To determine whether the translation of VSV messages was more resistant than cellular messages to the induction of eIF2 phosphorylation, VSV-infected and mock-infected cells were treated with 200nM thapsigargin, and the levels of protein synthesis were determined. Consistent with previous reports, the effects of thapsigargin were transient; protein synthesis was inhibited for approximately 2 hours, but thereafter began to recover (21) . This allowed us to determine both the acute effects of eIF2 phosphorylation, as well as the recovery of protein synthesis. Rates of protein synthesis were determined at 6 hours postinfection for both VSV-and mock-infected cells treated for various times with thapsigargin; a diagram of the experimental procedure is shown in figure 2A . Thapsigargin was added either coincident with infection (6 hours Tgn), 2 hours after infection (4 hours Tgn), 4 hours after infection (2 hours tgn) or 5 hours after infection (1 hour Tgn), and cells were then either pulse labeled to determine the rate of protein synthesis or lysed and analyzed for the state of eIF2 phosphorylation by western blotting.
Western blot analysis of VSV-infected, thapsigargin-treated cells (Figure 2B) showed that eIF2 was extensively phosphorylated following the 1 hour Tgn treatment, but little eIF2 phosphorylation was seen in cells infected with VSV alone for 6 hours. phosphorylation in these cells by western blotting (Figure 3D ), we found that there was a rapid phosphorylation of eIF2 that became apparent at 6hpi and increased up to 10hpi consistent with a role in blocking viral protein synthesis (band intensities of phospho eIF2a signal normalized to total eIF2a are printed at the bottom of the panel).
In cells expressing the eIF2 S51A mutant, protein synthesis was not markedly inhibited following thapsigargin treatment, consistent with previous results showing that the S51A mutant does not allow the phosphorylation of eIF2 and inactivation of protein synthesis. However, when these cells were infected with VSV, the time course of host protein synthesis inhibition was very similar to that seen in MEFs expressing wt eIF2 , so that by 6 hours postinfection host protein synthesis was largely inhibited (figure 3B, lanes 3-6) though viral protein synthesis continued for much longer. As expected, western blotting for eIF2 phosphorylation showed no signal in these cells ( Figure 3D ). 
EIF2 phosphorylation is disregulated in cells infected with the VSV M51R M protein mutant
The data shown above suggest that independent factors control viral and host protein synthesis during VSV infection. To further test this hypothesis, we used a virus containing a point mutant in the VSV matrix protein which is delayed in the inhibition of both host and viral translation. Figure 4A shows an autoradiograph of lysates from cells that were mock infected, or infected with isogenic recombinant viruses derived from cDNA clones containing either wt or M51R M proteins (rwt or rM51R-M virus, respectively) for the indicated times; after which they were pulse-labeled with 35 The sensitivity of VSV translation to eIF2 phosphorylation is fully consistent with previous reports showing that the activation of PKR (12, 27) and the subsequent phosphorylation of eIF2 (24, 26) is an important host defense mechanism against VSV infection. These studies showed that removing PKR or keeping eIF2 phosphorylation from blocking eIF2 function allows enhanced VSV replication. One question raised by these findings is how VSV still manages to replicate well in animal hosts like mice, where the PKR pathway is still intact. Our results showing a delay in eIF2 phosphorylation until after VSV has been producing both RNA and protein for a significant period of time (8hpi in BHK cells) suggests that the kinetics of eIF2 phosphorylation may be important for viral replication. The reason that some cell types are resistant to VSV infection and others are sensitive may result from the fact that cells which rapidly phosphorylate eIF2 are more resistant to VSV infection, while those that have a significant delay in eIF2 phosphorylation block viral protein synthesis at a point that is too late to inhibit effective replication. This idea is supported by our results, where BHK cells which replicate virus at titres up to 10 9 pfu, have a longer delay in eIF2 phosphorylation than do MEFs which only replicate VSV to titres of ~10 6 .
The previous reports showing that VSV infection inactivates the eIF2 complex, have all suggested that VSV infection rapidly induces the phosphorylation of eIF2 (28).
Our results showing a delay in eIF2 phosphorylation until after VSV has been producing both RNA and protein for well over 6 hours suggests a more complex interpretation. VSV infection has multiple triggers (dsRNA production, ER stress through G protein production, RNA synthesis inhibition, etc.) that could lead to the 
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